First AD

Second AD

Medical Content

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Recent Advances in Molecular Biomarkers in Multiple Myeloma

Drs Shaji Kumar and Jonathan Kaufman review the BELLINI trial, as well as provide an overview of other investigational studies of BCL2 inhibitors for the treatment of patients with t(11;14) translocation with relapsed refractory multiple myeloma.

Evidence Around BCL2 Inhibitors for Patients with t(11;14) Translocation in MM

Biomarkers in Multiple Myeloma (MM): Overview

Role of t(11;14) Translocation in Patients with MM

Emerging Biomarkers in Multiple Myeloma

Testing for Biomarkers in Multiple Myeloma

Future Perspectives in Biomarker Identification and Testing in MM